Fig 1: Serum levels of CCL21, IL-1β, LAG3, and VCAM-1. (A-D) ELISA kit was used to determine the serum level of CCL21 (A), IL-1β (B), LAG3 (C), and VCAM-1 (D) in participants in the NFD, DCM, and ICM groups. DCM, dilated cardiomyopathy; ICM, ischemic cardiomyopathy; CCL21, chemokine (C-C motif) ligand 21; IL-1β, interleukin-1β; LAG3, lymphocyte-activation gene 3; VCAM-1, vascular cell adhesion molecule-1; ELISA, enzyme-linked immunosorbent assay; NFD, non-failing donors.
Fig 2: ROC curve of CCL21, IL-1β, LAG3, and VCAM-1 in the serum for distinguishing between ICM and DCM. CCL21, chemokine (C-C motif) ligand 21; IL-1β, interleukin-1β; LAG3, lymphocyte-activation gene 3; VCAM-1, vascular cell adhesion molecule-1; ROC, receiver operating characteristic; ICM, ischemic cardiomyopathy; DCM, dilated cardiomyopathy.
Supplier Page from Abcam for Human Exodus 2 ELISA Kit (CCL21)